Unexpected gender differences in progressive supranuclear palsy reveal efficacy for davunetide in women.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Unexpected gender differences in progressive supranuclear palsy reveal efficacy for davunetide in women.
- Published In:
- Translational psychiatry, 13(1), 319 (2023)
- Authors:
- Gozes, Illana(2), Shapira, Guy, Lobyntseva, Alexandra, Shomron, Noam
- Database ID:
- RPEP-06916
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06916APA
Gozes, Illana; Shapira, Guy; Lobyntseva, Alexandra; Shomron, Noam. (2023). Unexpected gender differences in progressive supranuclear palsy reveal efficacy for davunetide in women.. Translational psychiatry, 13(1), 319. https://doi.org/10.1038/s41398-023-02618-9
MLA
Gozes, Illana, et al. "Unexpected gender differences in progressive supranuclear palsy reveal efficacy for davunetide in women.." Translational psychiatry, 2023. https://doi.org/10.1038/s41398-023-02618-9
RethinkPeptides
RethinkPeptides Research Database. "Unexpected gender differences in progressive supranuclear pa..." RPEP-06916. Retrieved from https://rethinkpeptides.com/research/gozes-2023-unexpected-gender-differences-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.